EUVIMEDEUVIMED entdecken
Crossref

Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities

Tomas Guman, Jan Sykora

Bratislava Medical Journal · 2023

DOI: 10.4149/bll_2024_002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bratislava Medical Journal, 2023. Verfasst von Tomas Guman und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Multiple Myeloma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationMultiple MyelomaHumansAntineoplastic Combined Chemotherapy ProtocolsChromosome AberrationsDisease ProgressionDisease-Free SurvivalProgression-Free SurvivalRetrospective StudiesStem Cell TransplantationTransplantation, AutologousTreatment Outcome

Stichwörter der Autor:innen

autologous stem cell transplantationmultiple myelomaoverall survival high-risk cytogenetics.progression free survival

Zitieren

APA

Guman, T., & Sykora, J. (2023). Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities. Bratislava Medical Journal. https://doi.org/10.4149/bll_2024_002

Vancouver

Guman T, Sykora J. Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities. Bratislava Medical Journal. 2023. doi:10.4149/bll_2024_002

BibTeX
@article{Guman2023,
  author = {Guman, Tomas and Sykora, Jan},
  title = {Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities},
  journal = {Bratislava Medical Journal},
  year = {2023},
  doi = {10.4149/bll_2024_002}
}
Kostenlos starten →